Opinion
No. 383, Docket 32665.
Submitted February 18, 1969.
Decided February 19, 1969.
Thomas D. Edwards, New York City, for appellant.
Gary P. Naftalis, Charles P. Sifton, Asst. U.S. Attys., Robert M. Morgenthau, U.S. Atty., for appellee.
Appellant claims that a seller of narcotic drugs who fails to comply with the requirements of 26 U.S.C. § 4705(a) may not be convicted for a violation of that section because a compliance would destroy the seller's Fifth Amendment privilege against self-incrimination. Appellant relies by analogy upon the United States Supreme Court holdings in Marchetti v. United States, 390 U.S. 39, 88 S.Ct. 697, 19 L.Ed.2d 889 (1968); Grosso v. United States, 390 U.S. 62, 88 S.Ct. 716, 19 L.Ed.2d 906 (1968); and Haynes v. United States, 390 U.S. 85, 88 S.Ct. 722, 19 L.Ed.2d 923 (1968).
We have held in four recent decisions of our court that the Fifth Amendment privilege against self-incrimination does not provide a defense to a prosecution for selling narcotic drugs without the mandatory written order form required by 26 U.S.C. § 4705(a). United States v. Oliveros, 398 F.2d 349 (2 Cir. 1968) (per curiam); United States v. Smith (2 Cir. October 1, 1968) (aff'd in open court); United States v. McLean (2 Cir. Dec. 9, 1968) (aff'd in open court); United States v. Minor, 398 F.2d 511 (2 Cir. 1968). We adhere to those rulings.
Conviction affirmed.